Your browser doesn't support javascript.
loading
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Graham, Danielle L; Gray, Audrey J; Joyce, John A; Yu, Dongzi; O'Moore, Jill; Carlson, George A; Shearman, Mark S; Dellovade, Tammy L; Hering, Heike.
Affiliation
  • Graham DL; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • Gray AJ; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • Joyce JA; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • Yu D; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • O'Moore J; McLaughlin Research Institute, Great Falls, MT 59405, USA.
  • Carlson GA; McLaughlin Research Institute, Great Falls, MT 59405, USA.
  • Shearman MS; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • Dellovade TL; EMD Serono Research & Development Institute, Billerica, MA 01821, USA.
  • Hering H; EMD Serono Research & Development Institute, Billerica, MA 01821, USA. Electronic address: heike.hering@emdserono.com.
Neuropharmacology ; 79: 307-13, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24326295

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrans / Acetylglucosamine / Thiazoles / Tau Proteins / Neuroprotective Agents / Tauopathies / Neurons Limits: Animals Language: En Journal: Neuropharmacology Year: 2014 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrans / Acetylglucosamine / Thiazoles / Tau Proteins / Neuroprotective Agents / Tauopathies / Neurons Limits: Animals Language: En Journal: Neuropharmacology Year: 2014 Document type: Article Affiliation country: United States